Basel Medical Group Ltd
BMGL
$2.02
-$0.17-7.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.48M | 7.48M | 7.46M | 7.36M | 7.26M |
| Total Other Revenue | 18.30K | 16.60K | 14.90K | 24.30K | 33.70K |
| Total Revenue | 7.50M | 7.50M | 7.47M | 7.39M | 7.30M |
| Cost of Revenue | 5.39M | 4.88M | 4.37M | 3.94M | 3.50M |
| Gross Profit | 2.12M | 2.61M | 3.10M | 3.45M | 3.79M |
| SG&A Expenses | 609.00K | 565.20K | 520.90K | 649.60K | 777.70K |
| Depreciation & Amortization | 460.80K | 427.30K | 392.30K | 383.00K | 373.20K |
| Other Operating Expenses | 1.28M | 943.80K | 603.80K | 441.30K | 277.30K |
| Total Operating Expenses | 7.73M | 6.82M | 5.88M | 5.41M | 4.93M |
| Operating Income | -233.30K | 675.40K | 1.59M | 1.98M | 2.37M |
| Income Before Tax | 107.40K | 944.40K | 1.78M | 2.18M | 2.58M |
| Income Tax Expenses | -207.40K | 19.10K | 245.60K | 481.00K | 718.10K |
| Earnings from Continuing Operations | 0.32 | 0.93 | 1.54 | 1.70 | 1.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 315.00K | 925.50K | 1.54M | 1.70M | 1.87M |
| EBIT | -233.30K | 675.40K | 1.59M | 1.98M | 2.37M |
| EBITDA | -207.30K | 699.60K | 1.61M | 2.00M | 2.39M |
| EPS Basic | 0.02 | 0.06 | 0.09 | 0.10 | 0.11 |
| Normalized Basic EPS | 0.00 | 0.04 | 0.07 | 0.08 | 0.10 |
| EPS Diluted | 0.02 | 0.06 | 0.09 | 0.10 | 0.11 |
| Normalized Diluted EPS | 0.00 | 0.04 | 0.07 | 0.08 | 0.10 |
| Average Basic Shares Outstanding | 65.00M | 65.00M | 65.00M | 65.00M | 65.00M |
| Average Diluted Shares Outstanding | 65.00M | 65.00M | 65.00M | 65.00M | 65.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |